MedPath

Early Urinary Continence After Radical Prostatectomy: Surgical Procedure and Anatomic Landmarks

Completed
Conditions
Urinary Incontinence
Surgical Procedure, Unspecified
Prostatic Cancer
Registration Number
NCT04043637
Lead Sponsor
Consorci Sanitari Integral
Brief Summary

This study describes how to perform a correct prostatic apex and membranous urethra in order to preserve all anatomical elements that are necessary to achieve a very fast urinary continence after open/laparoscopic/robotic radical prostatectomy, avoiding positive surgical margins at this level.

Detailed Description

This study describes a simple technical variation, aimed at the sparing of the muscle systems and neurovascular bundles in order to achieve high rates of urinary continence in the early postoperative period ( the first two months after surgery) in prostate cancer patients undergoing radical prostatectomy.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
120
Inclusion Criteria
  • Age between 40 and 75 years
  • A Body Mass Index lower than 35 Hg/m2
  • Patients with organ-confined prostate cancer
  • Signed informed consent
Exclusion Criteria
  • Contraindications for Laparoscopy

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
change in the proportion of patients with of urinary incontinenceThe follow-up was at 2 weeks, 4 weeks and 8 weeks after removal of the urethral catheter (one week after surgery), and, thereafter, once a month over the first year after surgery

Assessment of the proportion of patients with urinary incontinence after laparoscopic radical prostatectomy

Secondary Outcome Measures
NameTimeMethod
change in the proportion of patients with recovery of the erectile functionevery month during the first year after surgery

assessment of the recovery of the erectile function after surgery

number of patients with overall positive surgical marginsimmediate postoperative period

postoperative assessment of positive surgical margins

biochemical recurrence rateuntil the completion of the study, with a mean follow-up of 72 months
© Copyright 2025. All Rights Reserved by MedPath